Results 161 to 170 of about 62,879 (264)

Outcome of transcarotid transcatheter aortic valve replacement with balloon expandable valve. [PDF]

J Cardiothorac Surg
Nakai C, Azhagiri N, Liu J, Xing MZ, Tarabichi S, Danduch E, DeLago A, Samy S.   +7 more
europepmc   +1 more source

Impella‐Assisted High‐Risk Percutaneous Coronary Intervention in Cardiogenic Shock With Low‐Flow, Low‐Gradient Aortic Stenosis and Multivessel Coronary Artery Disease: A Case Report

Clinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT Patients with cardiogenic shock, low‐flow, low‐gradient aortic stenosis, and multivessel coronary artery disease who are ineligible for surgery present a major therapeutic challenge. Percutaneous mechanical circulatory support may facilitate revascularization in this high‐risk population. A 69‐year‐old man presented after a mechanical fall and
Douni Roger, Waleed Shaker, Zan Siddiqi, George Abela   +3 more
wiley   +1 more source

Evaluation of Risk Score for Isolated Surgical Aortic Valve Replacement and Transcatheter Aortic Valve Replacement-Results from the German National Quality Database. [PDF]

Interdiscip Cardiovasc Thorac Surg
Böning A, Beckmann A, Heinemann M, Doenst T, Taghiyev ZT, Niemann B.   +5 more
europepmc   +1 more source

A Closed‐Loop Cardiovascular Model of the Supine‐To‐Stand Manoeuvre: Implications for Falls

International Journal for Numerical Methods in Biomedical Engineering, Volume 42, Issue 8, August 2026.
Continuous beat‐to‐beat modeling of supine‐to‐stand hemodynamics in older adults reproduces orthostatic responses and reveals differences in baroreflex, muscle‐pressure, and blood volume in those with a fall history, providing a basis for mechanistic phenotyping to enhance orthostatic hypotension diagnosis.
Joeri A. van de Sande, Valeria Krzhizhanovskaya, Lex M. van Loon, Nathalie van der Velde, Eveline P. van Poelgeest, Marjolein Klop, Jurgen A. H. R. Claassen, Alfons G. Hoekstra   +7 more
wiley   +1 more source

Clinical outcomes following transcatheter aortic valve replacement in patients with concordant versus discordant aortic stenosis. [PDF]

Am Heart J Plus
Hundal P, Abood Z, Zlochiver V, Boulware D, Osman M, Jain R, Allaqaband S, Bajwa T, Tajik AJ, Jan MF.   +9 more
europepmc   +1 more source

Impact of Leaflet Thickness on Polymeric Valve Scaffold Function and Remodeling: Assessment in a 1‐ and 3‐Month Ovine Stented Pulmonary Valve Replacement Model

Journal of Biomedical Materials Research Part A, Volume 114, Issue 8, August 2026.
ABSTRACT Approaches to the structural design of tissue engineered heart valves (TEHVs) have varied broadly, ranging from material choice to microstructural and macro‐scale functional characteristics. Not only will each variable on this extensive list impact functional and restorative potential after implantation, but most of these variables also have ...
Drake D. Pedersen, Garrett Coyan, Viktor Balashov, Arianna Adamo, Patrizia Caruso, Flaviana Falci, Vesselin Shanov, William E. Katz, David Kokot, Giuseppe D'Ancona, William R. Wagner, Antonio D'Amore   +11 more
wiley   +1 more source

Evaluation and Management of Cardiac Tamponade During Transcatheter Aortic Valve Replacement. [PDF]

JACC Case Rep
Patil N, Kapadiya A, Anne UK, Gurram P, Menon R, Reddy SK.   +5 more
europepmc   +1 more source

The Therapeutic Potential of H2S‐Releasing Platforms in Cardiovascular Applications

Journal of Biomedical Materials Research Part B: Applied Biomaterials, Volume 114, Issue 8, August 2026.
The Therapeutic Potential of H2S‐Releasing Platforms. ABSTRACT Once known as a toxic gas, hydrogen sulfide (H2S) is now making its way into many therapeutic applications. Similar to its other fellow endogenous gasotransmitters, nitric oxide and carbon monoxide, H2S is a small gas with a short half‐life, making it extremely capable of penetrating ...
Tia N. Shorter, Elizabeth J. Brisbois
wiley   +1 more source

Antiplatelet Therapy and All-Cause Mortality After Transcatheter Aortic Valve Replacement: The TRITAVI Registry. [PDF]

JACC Adv
Pelliccia F, Pasceri V, Dangas G, Mehran R, Porto I, Radico F, Biancari F, D'Ascenzo F, Saia F, Luzi G, Bedogni F, Amat Santos IJ, De Marzo V, Dimagli A, Mäkikallio T, Stabile E, Blasco-Turrión S, Testa L, Barbanti M, Costa G, Fabbiocchi F, Chilmeran A, Stefanini G, Conrotto F, Tamburino C, Spaccarotella C, Cao D, Macchione A, La Torre M, Bendandi F, Wańha W, Wojakowski W, Benedetto U, Indolfi C, Hildick-Smith D, Capodanno D, Miraldi F, Dobrev D, Zimarino M, TRITAVI Study Group.   +39 more
europepmc   +1 more source

Myocardial Lipid Metabolism Imbalance: The Pathological Core and Novel Diagnostic‐Therapeutic Directions of Cardiovascular Diseases

Journal of Biochemical and Molecular Toxicology, Volume 40, Issue 8, August 2026.
In cardiac cells, Plin5/AMPK regulate lipid homeostasis; excess CD36‐mediated uptake drives lipotoxicity, mitochondrial dysfunction, and CVDs (e.g., heart failure). Biomarkers (ApoB/ApoA‐1) and therapies (SGLT2 inhibitors) target this cascade. ABSTRACT Cardiac lipid metabolism is fundamental to myocardial energy homeostasis, with fatty acid oxidation ...
Peiyun Xie, Qun Zeng, Hongrui Wang, Meihua She   +3 more
wiley   +1 more source